Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Clinical proof – Siemens' Artis Q.zen minimizes dose in cardiology

02.09.2013
- Significant dose reductions in electrophysiological examinations and interventional cardiology
- Angiography system with unique x-ray tube and detector

The new Artis Q.zen angiography system from Siemens has proven itself in everyday clinical practice. The system has been in use since November 2012 at the Basel University Hospital in Switzerland where both patients and staff benefit from the low radiation dose that an entirely novel technology has made possible.



"My team spends about three to four hours a day in the Electrophysiology Laboratory (EP) in connection with about eight to ten operations. This is why reducing the dose is so important," says Prof. Stefan Osswald, head of the cardiology department. With Artis Q.zen, Siemens is demonstrating its innovative strength as part of the global "Agenda 2013" Sector initiative.

Studies show that on average one in four people suffer from atrial fibrillation, the most widespread form of cardiac arrhythmia, at some stage during their lives. A further increase can be expected as a result of demographic change. Electrophysiological studies and interventions can be used to examine and treat a large number of patients. This involves ablating tiny points in the myocardial tissue using an ablation catheter in order to return the heart to its correct rhythm. Depending on the level of complexity, this type of procedure can take two to three hours. Each misrouting of the electrical impulses that trigger cardiac arrhythmia, which is measured in milliseconds, must first be located and mapped using electrophysiology catheters. It is only at that point that the doctor can develop an individual treatment plan tailored to the patients' needs. Prof. Osswald has been working with Artis Q.zen since November 2012. "We can now manage with radiation doses that are up to 85 percent below usual values," he says. This benefits both patients and staff alike.

In addition to cardiac arrhythmia, there is another clinical picture in the field of cardiology that is on the rise, and is the most frequent cause of death in the industrialized nations: coronary heart disease. This involves narrowing and blockage of the arteries supplying blood to the heart muscle. In Europe alone, over 1.8 million people die of this chronic disease each year. Narrowings – known as stenoses – can be widened using balloon catheters to restore the flow of blood. Stents keep the constricted locations permanently open. During this procedure, known as percutaneous coronary intervention (PCI), the cardiologist has to position the stent with millimeter precision despite cardiac movement. Using Artis Q.zen, the cardiologist is supported by the advanced guidance of Clearstent Live. With Clearstent Live, stent enhancement takes place in real time. The software eliminates cardiac movement, allowing cardiologists to verify stent positioning relative to the cardiac anatomy or to previously deployed stents. The enhanced images are displayed side-by-side with the current live-image without any noticeable lag and while the operator can still move the balloon mounted stent. In interventions of this nature, Prof. Osswald has observed a clear reduction in dose compared to the previous model, up to 50 percent. "The main advantage is the massively better visualization of the stent and the respective vessel-section. Hence, additional images to decide whether the stent has been fully expanded are no longer necessary," says Prof. Osswald.

Introduced by Siemens during the Radiological Society of North America (RSNA) congress last year, the Artis Q.zen comes with two new advances making it possible to reduce the radiation dose while maintaining and improving the quality – a new x-ray tube and a new detector. The x-ray tube is the only one on the market exclusively equipped with "flat emitter" technology. The new tube permits the system to generate detailed images of moving objects and even the smallest vessels in a beating heart within a very short time at a maximum current of 1,000 milliamperes (mA). The new technology delivers a more richly detailed image for the subsequent treatment.

The new Artis Q.zen detector enables x-ray checks to be performed in the ultra-low dose range, i.e. 20 nanograys (nGy) or less. What is new and unique worldwide is the fact that the detector is based on crystalline rather than on amorphous silicon technology. This is a material of homogenous chemical structure used mainly in the solar industry. It ensures that the image signal is enhanced with substantially reduced electronic noise in the image. This means that the cardiologist can achieve the same image quality using a lower dose.

Follow us on Twitter: www.twitter.com/siemens_press

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2012 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 1.8 billion euros. For further information please visit: http://www.siemens.com/healthcare

The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.

Reference Number: HIM201308020e

Contact
Ms. Kathrin Schmich
Healthcare Sector
Siemens AG
Henkestr. 127
91052 Erlangen
Germany
Tel: +49 (9131) 84-5337
Kathrin.Schmich​@siemens.com

Kathrin Schmich | Siemens Healthcare
Further information:
http://www.siemens.com/presse/esc2013

More articles from Medical Engineering:

nachricht New imaging technique able to watch molecular dynamics of neurodegenerative diseases
14.07.2017 | The Optical Society

nachricht Quick test finds signs of sepsis in a single drop of blood
03.07.2017 | University of Illinois at Urbana-Champaign

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

Im Focus: Laser-cooled ions contribute to better understanding of friction

Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision

Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

Chances to treat childhood dementia

24.07.2017 | Health and Medicine

Improved Performance thanks to Reduced Weight

24.07.2017 | Automotive Engineering

NASA looks to solar eclipse to help understand Earth's energy system

21.07.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>